Key Benefits

• Understand why getting pregnant is hard by checking key reproductive hormone signals.
• Spot ovulation problems by confirming progesterone rise and a coordinated LH–FSH response.
• Flag diminished ovarian reserve with high day-3 FSH or elevated estradiol levels.
• Clarify polycystic ovary syndrome risk when LH exceeds FSH and cycles are irregular.
• Explain missed periods or unexpected lactation by checking prolactin for pituitary causes.
• Guide thyroid care to protect ovulation and early pregnancy by measuring TSH.
• Protect implantation by identifying estrogen–progesterone imbalance that can thin the uterine lining.
• Track treatment success and cycle timing by repeating tests on targeted cycle days.

What are Female Infertility biomarkers?

Female infertility biomarkers are blood signals that reveal how the reproductive system is functioning. They turn the cycle’s hidden rhythms into a readable map of egg supply, ovulation, and hormone coordination. Ovarian reserve is reflected by a follicle‑derived hormone that mirrors the remaining egg pool (anti‑Müllerian hormone, AMH). Brain‑to‑ovary messengers drive follicle growth and the ovulatory surge (follicle‑stimulating hormone, FSH; luteinizing hormone, LH). Ovarian hormones show follicle maturation and luteal activity (estradiol, E2; progesterone). Thyroid and lactation hormones influence ovulation and cycle regularity (thyroid‑stimulating hormone, TSH; prolactin). Androgen and metabolic markers point to hormone excess or insulin effects that can disrupt ovulation (testosterone, DHEA‑sulfate, sex hormone–binding globulin, insulin). Reviewed together, these tests create a functional picture of the hypothalamic–pituitary–ovarian axis and its modifiers, clarifying where signals may be mistimed or opposed. The result is practical: biomarker testing makes the physiology visible, so care can target the right step—diagnosis, cycle timing, and treatment planning.

Why is blood testing for Female Infertility important?

Female infertility blood tests map how the brain, pituitary, thyroid, and ovaries coordinate ovulation and uterine readiness. They reveal whether the system is under‑signaling, over‑signaling, or well‑timed—key for egg development, release, fertilization, and implantation.In a typical early cycle, FSH and LH sit in the low–middle range, estradiol is modest and then rises before ovulation, and progesterone is low until after ovulation when it climbs in the mid‑luteal phase. Prolactin usually stays low–normal; TSH tends to be most fertility‑friendly in the lower to mid‑normal band. Higher‑than‑expected FSH points to diminished ovarian reserve, while a relatively high LH (especially with normal FSH) can reflect ovarian androgen excess. Elevated prolactin suppresses GnRH and can halt ovulation. A high TSH signals hypothyroidism, which can lengthen cycles and impair implantation; very low TSH suggests hyperthyroidism, which also disrupts cycles.When these values are low, physiology often points to under‑drive from the hypothalamus or pituitary. Low FSH and LH mean follicles don’t mature, estradiol stays low, periods become light or absent, and ovulation may not occur; teens may have delayed puberty, and adults can notice low libido and bone loss risk over time. Low mid‑luteal progesterone reflects weak or absent ovulation, shortening the luteal phase and making implantation less likely. Low prolactin is uncommon but can indicate pituitary injury with poor milk production. Suppressed TSH from hyperthyroidism brings palpitations, weight loss, anxiety, and irregular bleeding.Big picture, these hormones are the timing signals of reproduction and also influence brain mood circuits, bone, metabolism, and cardiovascular risk. Aligning them clarifies causes of infertility, distinguishes ovarian from central or thyroid drivers, and informs prognosis for cycle regularity, egg quality, and long‑term health.

What insights will I get?

Female infertility blood testing provides a window into the hormonal systems that govern not only reproduction, but also energy balance, metabolism, and overall endocrine health. At Superpower, we measure six key biomarkers—FSH, LH, Estradiol, Progesterone, Prolactin, and TSH—to map the hormonal signals that orchestrate the menstrual cycle and fertility. These hormones interact in a finely tuned network, influencing ovarian function, egg maturation, and the ability to conceive.FSH (follicle-stimulating hormone) and LH (luteinizing hormone) are pituitary hormones that regulate the growth and release of eggs from the ovaries. Estradiol, a form of estrogen, is produced by the ovaries and signals the readiness of the reproductive system. Progesterone, also from the ovaries, prepares the uterine lining for implantation. Prolactin, another pituitary hormone, primarily controls milk production but can also affect ovulation. TSH (thyroid-stimulating hormone) reflects thyroid function, which is closely linked to menstrual regularity and fertility.Balanced levels of these hormones support stable menstrual cycles, healthy ovulation, and optimal conditions for conception. Disruptions—such as elevated FSH or prolactin, low estradiol or progesterone, or abnormal TSH—can signal underlying issues with ovarian reserve, ovulation, or thyroid health, all of which can contribute to infertility.Interpretation of these biomarkers depends on factors like age, menstrual phase, pregnancy status, recent illness, medications, and laboratory methods. These variables can influence hormone levels and should be considered when evaluating results.